Sponsored by the China Association of Chinese Medicine, organized by the Hematology Branch of the China Association of Chinese Medicine and the Dongzhimen Hospital of Beijing University of Chinese Medicine, the "Fourth Academic Annual Meeting and General Election Meeting of the Hematology Branch of the China Association of Chinese Medicine" was held in Beijing Yuyang Hotel from November 2 to November 4, 2018.
The conference was attended by Li Yu, Director of the Department of Science and Technology of the State Administration of Traditional Chinese Medicine, Xu Anlong, President of Beijing University of Traditional Chinese Medicine, Tu Zhitao, Director of Beijing Municipal Administration of Traditional Chinese Medicine, Liu Ping, Deputy Secretary-General of the China Association of Traditional Chinese Medicine, Yan Jun, Vice President of Dongzhimen Hospital of Beijing University of Chinese Medicine, and more than 500 hematology experts and scholars from 23 provinces, 5 autonomous regions, 4 municipalities directly under the Central Government and the Hong Kong Special Administrative Region. The conference was chaired by Professor Chen Xinyi from Dongzhimen Hospital of Beijing University of Chinese Medicine and Professor Yang Wenhua from the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, and the opening ceremony was presided over by Hou Li, Director of the Department of Hematology and Oncology of Dongzhimen Hospital of Beijing University of Chinese Medicine.
Xinyi of Dongzhimen Hospital of Beijing University of Chinese Medicine was re-elected as the chairman of the branch.
With the theme of "Attaching Importance to Immune Regulation and Maintaining Blood Homeostasis", the conference specially invited 18 well-known experts, including Professor Xu Anlong of Beijing University of Chinese Medicine, Professor Wang Changen of the National Natural Science Foundation of China, Professor Chang Yingjun of the Institute of Hematology of Peking University, Professor Shi Yuankai of the Cancer Hospital of the Chinese Academy of Medical Sciences, Professor Yang Wenhua of the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, and Professor Chen Zhixiong of the First Affiliated Hospital of Guangzhou University of Chinese Medicine to make wonderful academic reports. The content of the report covers the latest progress in basic research and clinical research of immunotherapy, the design and application of scientific research topics, the study of the immune mechanism of traditional Chinese medicine in the treatment of blood diseases, the clinical research of traditional Chinese medicine and the latest progress in the diagnosis of blood diseases。
At the same time, in order to better inherit the quintessence of the country and reward post-learning, the conference set up a unique "old expert interview session", and invited Professor Liang Bing, Professor Deng Chengshan, Professor Li Jianhua, Professor Tang Youjun, Professor Chen Anmin, Professor Jiang Hongyu, Professor Le Zhaosheng, Professor Sun Yingli, Professor Sun Weizheng, Professor Wang Changen and other 11 well-known old experts in traditional Chinese medicine and integrated Chinese and Western medicine hematology to share their rich clinical experience, benevolent and benevolent doctors' feelings and hard work for the cause of Chinese medicine hematology, which was deeply moving.
With the official inclusion of Shengbai Oral Liquid (Mixture) in the 2018 edition of the "Clinical Pathway Therapeutic Drug Interpretation: Blood Disease Division" for the treatment of Chinese patent medicine for blood diseases, Mengyang Pharmaceutical will do its best to bring more gospel to patients and strive to become a leading R&D and manufacturer of oral anti-cancer Chinese medicine in China.
